Phospho-HIST1H1C (T164) Antibody detects the phosphorylation of HIST1H1C (Histone H1.2) at threonine residue 164. This modification occurs in the C-terminal tail of the linker histone H1, which plays a role in chromatin compaction and transcriptional regulation . The antibody is generated using a synthetic peptide corresponding to the phosphorylated T164 epitope of human HIST1H1C (UniProt ID: P16403) .
Phosphorylation of HIST1H1C at T164 is associated with mitotic progression. Studies show that H1.2 phosphorylation at T165 (a homologous site in other variants) peaks during metaphase and decreases during anaphase/telophase .
This modification correlates with chromatin condensation and exclusion from metaphase chromosomes, suggesting a role in mitotic chromatin reorganization .
Immunofluorescence studies reveal that phosphorylated H1 variants, including HIST1H1C (T164), localize to the perichromosomal layer during mitosis, distinct from unmodified H1 .
In interphase cells, HIST1H1C (T164) phosphorylation is detectable at low levels, primarily in condensed chromatin regions .
HIST1H1C phosphorylation modulates chromatin accessibility, influencing transcriptional activity and DNA repair .
Aberrant phosphorylation patterns are linked to diseases such as cancer, where histone H1 dysregulation affects tumor progression .
Specificity: Antibodies targeting phosphorylated H1 require rigorous validation due to sequence homology among H1 variants and overlapping post-translational modifications (PTMs) .
Mitotic Detection: Phospho-HIST1H1C (T164) Antibody may fail to recognize hyperphosphorylated H1 during certain mitotic stages due to epitope masking .
The table below contrasts Phospho-HIST1H1C (T164) Antibody with other H1 phosphorylation-targeting tools :